The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins

被引：16

作者：

Dooley, Matthew M. ^{[1
]}

de Gannes, Samantha L. ^{[1
]}

Fu, Kristi A. ^{[1
]}

Lindsey, J. William ^{[1
]}

机构：

[1] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, 6431 Fannin St, Houston, TX 77030 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2016年 / 299卷

关键词：

Multiple sclerosis; Epstein-Barr virus; Antibody response; EBNA-1; BFRF3; BRRF2; IMMUNE-RESPONSE; INFECTION; RISK;

D O I：

10.1016/j.jneuroim.2016.08.016

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Multiple sclerosis (MS) is associated with Epstein-Barr virus (EBV) infection, and the antibody response to EBV is reported to be increased in MS. EBV contains multiple antigens, and only a few have been investigated. Our hypothesis is that MS patients will have an increased antibody response to only selected EBV antigens. We used immunoprecipitation and quantitative mass spectrometry to identify candidate EBV antigens. We then measured the antibody response to 10 individual EBV proteins with quantitative ELISA. We found that the antibody response was increased in MS to three of the EBV proteins, but not to the other seven. (C) 2016 Elsevier B.V. All rights reserved.

引用

页码：147 / 151

页数：5

共 21 条

[1] Epstein-Barr virus and multiple sclerosis
Ascherio, A
Munch, M
[J]. EPIDEMIOLOGY, 2000, 11 (02) : 220 - 224
[2] EPSTEIN-BARR VIRUS-INFECTION AND ANTIBODY-SYNTHESIS IN PATIENTS WITH MULTIPLE-SCLEROSIS
BRAY, PF
BLOOMER, LC
SALMON, VC
BAGLEY, MH
LARSEN, PD
[J]. ARCHIVES OF NEUROLOGY, 1983, 40 (07) : 406 - 408
[3] Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
Cepok, S
Zhou, D
Srivastava, R
Nessler, S
Stei, S
Büssow, K
Sommer, N
Hemmer, B
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) : 1352 - 1360
[4] VIRAL-INFECTION IN PATIENTS WITH MULTIPLE-SCLEROSIS AND HLA-DR MATCHED CONTROLS
COMPSTON, DAS
VAKARELIS, BN
PAUL, E
MCDONALD, WI
BATCHELOR, JR
MIMS, CA
[J]. BRAIN, 1986, 109 : 325 - 344
[5] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Hauser, Stephen L.
Waubant, Emmanuelle
Arnold, Douglas L.
Vollmer, Timothy
Antel, Jack
Fox, Robert J.
Bar-Or, Amit
Panzara, Michael
Sarkar, Neena
Agarwal, Sunil
Langer-Gould, Annette
Smith, Craig H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) : 676 - 688
[6] Proteins of purified Epstein-Barr virus
Johannsen, E
Luftig, M
Chase, MR
Weicksel, S
Cahir-McFarland, E
Illanes, D
Sarracino, D
Kieff, E
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (46) : 16286 - 16291
[7] PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis
Larman, H. Benjamin
Laserson, Uri
Querol, Luis
Verhaeghen, Katrijn
Solimini, Nicole L.
Xu, George Jing
Klarenbeek, Paul L.
Church, George M.
Hafler, David A.
Plenge, Robert M.
Nigrovic, Peter A.
De Jager, Philip L.
Weets, Ilse
Martens, Geert A.
O'Connor, Kevin C.
Elledge, Stephen J.
[J]. JOURNAL OF AUTOIMMUNITY, 2013, 43 : 1 - 9
[8] The antibody response to Epstein-Barr virions is altered in multiple sclerosis
Lindsey, J. W.
Khan, U.
Ansari, W.
Powell, T.
Wang, Y. H.
Guirguis, M. S.
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2013, 254 (1-2) : 146 - 153
[9] Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis
Lindsey, J. W.
Hatfield, L. M.
Vu, T.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (10) : 1263 - 1269
[10] Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L
Lindsey, J. William
Degannes, Samantha L.
Pate, Kimberly A.
Zhao, Xiurong
[J]. MOLECULAR IMMUNOLOGY, 2016, 69 : 7 - 12

← 1 2 3 →